Back
ESC Premium Access

Lifetime mortality associated with hypertrophic cardiomyopathy: 28-year outcome of an historical cohort

Session: Advances in Pathophysiology and Treatment of Hypertrophic Cardiomyopathy
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor N. Maurizi (Lausanne, CH)
Event: ESC Congress 2020

Congress Presentation

Add to my library

Like

About the speaker

Doctor Niccolo' Maurizi

University Hospital of Lausanne, Lausanne (Switzerland)
4 presentations
0 follower

3 more presentations in this session

What happens >10 years after percutaneous septal ablation for hypertrophic obstructive cardiomyopathy? Ultra long-term follow-up of 120 patients.

Speaker: Professor L. Faber (Bünde, DE)

Access
Abstract
Slides
Like
Thumbnail

Is alcohol septal ablation in women performed too late?

Speaker: Doctor A. Batzner (Wurzburg, DE)

Access
Abstract
Slides
Like
Thumbnail

High sensitivity troponin I in hypertrophic cardiomyopathy

Speaker: Doctor J. Osmanska (Glasgow, GB)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Advances in Pathophysiology and Treatment of Hypertrophic Cardiomyopathy

Speakers: Doctor N. Maurizi, Professor L. Faber, Doctor A. Batzner, Doctor J. Osmanska
Access
Like
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources